Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark

Overview of attention for article published in Frontiers in Pharmacology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 12,824 followers.

RT @XBayona: 👉🏼👉🏼 "#Flecainide use was associated with an increased #risk of #melanoma (Denmark only) and #NMSC (#Denmark and #Spain) but w…

19 Mar 2023

Reply Repost Favourite

👉🏼👉🏼 "#Flecainide use was associated with an increased #risk of #melanoma (Denmark only) and #NMSC (#Denmark and #Spain) but without substantial evidence of dose-response patterns" #PrimumNonNocere

13 Mar 2023

Reply Repost Favourite

RT @IDIAPJGol: Nou article de: Reyes C, León-Muñoz LM, Pistillo A, Jóhannesdóttir Schmidt SA, Kristensen KB, Puente D, LLorente-García A, H…

13 Mar 2023

Reply Repost Favourite

Nou article de: Reyes C, León-Muñoz LM, Pistillo A, Jóhannesdóttir Schmidt SA, Kristensen KB, Puente D, LLorente-García A, Huerta-Álvarez C, Pottegård A, Duarte-Salles T. https://t.co/0Q9qDG3JSs https://t.co/v8VGkqvXwA

13 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.